Tartar 发表于 2025-3-30 10:58:30

Gruppenargeted antibodies and the high potency of small-molecule drugs with the aim of achieving durable responses in patients. As application of highly potent small-molecule drugs can be limited by their undesirable toxicity, targeted delivery of highly potent small-molecule drugs to specific cells is int

irritation 发表于 2025-3-30 14:00:37

http://reply.papertrans.cn/27/2700/269951/269951_52.png

严峻考验 发表于 2025-3-30 19:28:35

http://reply.papertrans.cn/27/2700/269951/269951_53.png

jocular 发表于 2025-3-30 21:33:31

https://doi.org/10.1007/978-981-13-0496-5Monospecific concepts; Bi-specific constructs; Nanobodies; Immune-oncology; Cancer; Preclinical studies; C

mercenary 发表于 2025-3-31 02:43:25

http://reply.papertrans.cn/27/2700/269951/269951_55.png

和平 发表于 2025-3-31 08:10:21

http://reply.papertrans.cn/27/2700/269951/269951_56.png
页: 1 2 3 4 5 [6]
查看完整版本: Titlebook: Development of Antibody-Based Therapeutics; Translational Consid Mohammad A. Tabrizi,Gadi G. Bornstein,Scott L. Kla Book 2018Latest edition